Developmental Dysplasia of the Hip
Tracking Pixel
presents
Wheeless' Textbook of Orthopaedics

Sickle Cell Anemia: Musculoskeletal Aspects



- See: Osteomyelitis in Sickle Cell Patient:

- Discussion:
    - affects 1% of blacks - is more severe but less common than sickle cell trait (8% prevalence);
    - two main genotypes include Hb S and Hb C forms of disease;
    - crises usually begin at age 2-3 years and may lead to bone infarctions;

- Sequelae of Sickle Cell:
    - growth retardation & skeletal immaturity;
    - pathologic fracture:
          - references:
                - Fractures in Thalassemia.   DM Dines et al.   JBJS. Vol 58-A. 1976. p 662-666.
                - Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
                - Incidence and treatment of fractures in thalassemia.
    - osteomyelitis (often in diaphysis);
          - septic arthritis (probably best treated w/ 3rd generation cephalsporin)
          - staph is probably the most common infectious organism, but some studies have shown salmonella to be common as well;
          - aspiration may be necessary to differentiate infarction from swelling;
          - references:
                - Original Articles: Pain In Sickle Cell Disease: Rates and Risk Factors.
                - Osteomyelitis in Patients Who Have Sickle-Cell Disease.   Diagnosis and Management.
                - Osteomyelitis in Patients Who Have Sickle-Cell Disease.   Diagnosis and Management.
                - Systemic Salmonella infections in sickle cell anaemia.
    - pneumococcal infection:
          - pneumococcal septicemia & meningitis are leading causes of death;
          - ensure pneumococcal vaccine;
          - consider penicillin prophylaxsis
    - AVN of femoral head:
          - more common in the older child (prevalence peaks in adolescence)
          - develops by the age of 35 years in nearly half of all patients with homozygous sickle cell disease;
          - femoral AVN occurs in about 30-37 % of patients and humeral head involvement occurs in about 50 % of patients;
                  - among patients with AVN of hip, opposite side will be involved in over 50% of cases;
          - rate of AVN is higher when patients are aggresively screened with bone scan (bone scan may also reveal AVN of knees and lumbar vertebrae);
          - naturual history:
                  - in children may produce the typical Perthes appearance in the younger child, with complete collapse of the femoral head;
                  - without intervention, the rate of femoral head collapse may be 87% or higher within 5 years after the initial diagnosis of the osteonecrosis;
          - surgical treatment: varus osteotomy, Chiari osteotomy, THR;
          - references:
                  - Osteonecrosis of the hip in the sickle-cell diseases. Treatment and complications.
                  - Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. A natural history of fifty-two patients.
                  - Sickle cell disease and silent avascular necrosis of the hip.
                  - Original Articles: Sickle Cell Disease As A Cause Of Osteonecrosis Of The Femoral Head.
                  - Hip arthroplasty in patients with sickle-cell haemoglobinopathy.
                  - Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy.
                  - Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease.   Orthopedics. Apr 2000. p 357
                  - The Natural History of Symptomatic Osteonecrosis in Adults with Sickle-Cell Disease.



    - AVN of humeral head:
          - femoral AVN occurs in about 30 % of patients and humeral head involvement occurs in about 50 % of patients;
          - in the report by Hernigou et al 1997, treatment of bone marrow allograft led to normalization
                  of the proximal humerus in a skeletally immature patient (w/ humeral AVN);
          - references:
                  - Bone Marrow Transplantation in Sickle Cell Disease.   Effect on Osteonecrosis. A case report with a four year follow up.
                        P Hernigou MD et al.   JBJS Vol 79-A.   No 11. Nov 1997. p 1726.
                  - The shoulder in sickle cell disease.   HG David et al.   JBJS. Vol 75-B. 1993. p 538-545.
                  - The shoulder in sickle-cell disease.
                  - Osteonecrosis of the humeral head in sickle cell disease.
    - dactylitis (acute hand/foot swelling):
          - affects 20%-50% of children with sickle cell disease;
          - usually occurs between ages of 6 months and 2 years;
          - presents w/ swelling of hands and feet, limitation of motion of extremities, & elevated temperature,
                thought to be result of vascular occlusion;
          - radiologic findings:
                - small osteolytic lesions in metacarpals, metatarsals;
                - phalanges show periostitis;
          - dactylitis is self limiting after a few days or weeks;
          - references:
                - Sickle-cell dactylitis.


- Bone Scan:
    - infarcts cause a persistent decrease in tracer uptake which may complicate matters if osteomyelitis sets in;
    - in the report by DL Skaggs et al, JBJS Vol 83-A, No 12, Dec 2001, the authors used radionucleotide scanning inorder to
          distinguish between bone infarction and acute osteomyelitis;
          - a radionucleotide bone marrow and bone scan was performed sequentially within a 24 hr period in 79 episodes of acute bone pain;
          - 70 cases of bone infarction were diagnosed on the basis of decreased uptake on bone marrow scans, and abnormal uptake
                  on the bone scan;


- PreOp Planning:
    - transfusion of pRBC to lower the percentage of hemoglobin S to less than 45% is recommended preoperatively;
          - consider the need for preop exchange transfusion;
    - transfusion may be combined with adequate preoperative hydration, avoidance of intraopeative hypothermia,
          maintenance of blood volume, and postop O2 (35%) and hydration;
          - Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
          - Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia.
    - fluids: once patient is NPO: rate of 3 L/msq/24 hr until PO fluid OK;
    - avoidance of intraopeative hypothermia;
    - postop O2 (35%) and hydration;
    - tourniquet use:
          - Stein and Urbaniak, CORR 1980
                - no contraindication to use of tourniquets, no incr complications;
          - references:
                - Use of the tourniquet during surgery in patients with sickle cell hemoglobinopathies.






Acute surgical illness in patients with sickle cell anemia.









Original Text by Clifford R. Wheeless, III, MD.